Big Care Starts Small: The Infant-sized MRI Scanner
Intensive Care Unit (NICU), every moment is a balance between fragility and strength. Parents hold tightly to hope as medical teams work to safeguard the tiniest lives. At Cincinnati Children’s Hospital, a new innovation is changing what’s possible: the Ascent3T Neonatal MRI System. This breakthrough scanner offers safer, faster, and more precise care, reshaping what’s possible for the tiniest patients.
Barriers to Infant Imaging
For decades, NICU patients rarely received MR scans because transporting them to a hospital’s main imaging suite posed serious safety concerns. For the sickest infants, the risks often outweighed the benefits. As a result, doctors were sometimes left without the detailed information they needed to guide treatment decisions.
A Safer Alternative
MRI scans are especially valuable in neonatal care. They can reveal crucial details, such as the extent of brain injury after a complicated birth. Yet, for critically ill infants, the journey to the main imaging suite was loaded with danger. Transport exposed them to possible infection, unstable body temperatures, and sudden medical complications. Too often, the risks outweighed the benefits, and physicians had to proceed without essential data.
This challenge inspired Charles Dumoulin and his team to envision an imaging tool that could provide critical information without moving fragile infants through the hospital. Their goal was to design a system tailored for newborns, one that minimizes disruption to care, lowers the chance of infection or injury, and eases the stress families face during an already difficult time.
The result was the Ascent3T Neonatal MRI System. With this innovation, infants can remain safely in their isolette and be gently positioned on the MR table without ever leaving the NICU. By eliminating transport, the scanner reduces medical risks while offering peace of mind to both families and healthcare providers
Redefining Neonatal Care
The infant-sized MR scanner has the potential to transform how hospitals worldwide care for their most vulnerable patients, making lifesaving information more accessible and reducing risks at the same time.
For now, the system remains under research use. It has not yet been cleared by the U.S. Food and Drug Administration (FDA) for commercial availability. Eyas Medical Imaging is conducting research studies at Cincinnati Children’s and hopes to apply for FDA 510(k) clearance soon, a step that could bring this technology to NICUs across the country and beyond.
Looking ahead, this innovation represents far more than a technological milestone. For families and clinicians alike, the Ascent3T Neonatal MRI System stands as a symbol of hope, safety, and the beginning of a new era in neonatal care.
References



Comments